Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111M
-
Number of holders
-
243
-
Total 13F shares, excl. options
-
91.7M
-
Shares change
-
-3.17M
-
Total reported value, excl. options
-
$1.19B
-
Value change
-
-$65.9M
-
Put/Call ratio
-
0.2
-
Number of buys
-
131
-
Number of sells
-
-122
-
Price
-
$12.92
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2025
302 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2025.
NovoCure Ltd - Common Stock (NVCR) has 243 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.7M shares
of 111M outstanding shares and own 82.57% of the company stock.
Largest 10 shareholders include FMR LLC (16.8M shares), BlackRock, Inc. (13.9M shares), VANGUARD GROUP INC (10.5M shares), Soleus Capital Management, L.P. (9.64M shares), STATE STREET CORP (2.61M shares), GEODE CAPITAL MANAGEMENT, LLC (2.47M shares), Capital World Investors (2M shares), Nuveen, LLC (1.71M shares), Quantinno Capital Management LP (1.52M shares), and MILLENNIUM MANAGEMENT LLC (1.34M shares).
This table shows the top 243 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.